P-048. Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients

INTRODUCTION: The aims of the present study were to assess the rates of hepatitis B virus (HBV) reactivation and to identify the predictors of relapse in CHB who discontinued entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy. METHODS: Between January 2015 and January 2017,36 non-cirrhot...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Turk J Gastroenterol
Päätekijät: Şah, Fatma Tuğçe, Keskin, Onur, Karakaya, Fatih, Ellik, Zeynep, Kartal, Aysun Çalışkan, Yurdcu, Esra, Bozdayı, Mithat, Idilman, Ramazan, Yurdaydın, Cihan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Turkish Society of Gastroenterology 2019
Aiheet:
AASLD - TASL CONNECT REGIONAL MEETING, March 15–16, 2019 - İstanbul, Turkey
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021077/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.54
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia